Vincent Serra
Chief Operating Officer chez NEOVACS
Profil
Founder of Wittycell SAS, Vincent Serra currently is Chief Operations & Scientific Officer at Neovacs SA. Dr. Serra is also Vice President of BioSupport AG.
In his past career he was VP-Research & Development Viral Vaccines Division at Abivax SA and Chief Executive & Scientific Officer at Wittycell SAS (a subsidiary of Abivax SA) and Vice President-European Operations at Anosys, Inc.
He received a doctorate from the University of Grenoble.
Postes actifs de Vincent Serra
Sociétés | Poste | Début |
---|---|---|
NEOVACS | Chief Operating Officer | - |
BioSupport AG | Corporate Officer/Principal | - |
Anciens postes connus de Vincent Serra
Sociétés | Poste | Fin |
---|---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Chief Executive Officer | 01/02/2014 |
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 01/02/2005 |
ABIVAX | Corporate Officer/Principal | - |
Formation de Vincent Serra
University of Grenoble | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
NEOVACS | Health Technology |
ABIVAX | Health Technology |
Entreprise privées | 3 |
---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
BioSupport AG |